• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
'Press Releases' Section describes most distant clients with latest product-specific, company-related updates is a key value addition to our members because they can use this platform as the easiest, earlier and the most effective means to get noticed quickly. Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Healthcare industry.

To learn more on how to reach a suitable target audience by distributing / publicizing your content(the latest happenings about your company) as in 'Press Releases' through 'Global Healthcare Technology', This email address is being protected from spambots. You need JavaScript enabled to view it.
Chemfort(TM) and Tevadaptor(R)

Simplivia Healthcare Ltd. announced today the first acquisition as part of its accelerated growth strategy

Simplivia is a leading global medical device developer and manufacturer of Closed System Transfer Devices (CSTDs). CSTDs are used to protect pharmacists, nurses, and other medical professionals in hospital settings from exposure to hazardous drugs, most often oncology drugs. They also ensure drug sterility to protect patients.

Read more →
ActivePure Technology

Clinical Trial to Study Impact of ActivePure Technology on Surgical Site Infections

Aerus Medical formally announced the start of a double-blind two-year clinical study to evaluate the impact the Aerus Medical Guardian with ActivePure Technology can have on reducing nosocomial infections, or healthcare-associated infections, also known as HAIs, from surgical operating room procedures.

Read more →
Neurapheresis platform

Minnetronix Medical Awarded National Institutes of Health Grant for Proprietary Neurapheresis Product That Removes Blood From Spinal Fluid

Minnetronix Medical, which partners with companies throughout the world to design, develop and manufacture medical device technology, today announced that it has been awarded a National Institutes of Health (NIH) granti for continued study of its proprietary Neurapheresis™ Cerebrospinal Fluid Treatment Platform.

Read more →

We use cookies to ensure you get the best experience on this website Privacy Policy